Global Sleep Apnea Devices Market Size study & Forecast, by Product Type (Diagnostic Devices, Therapeutic Devices, Sleep Apnea Masks) and Regional Analysis, 2023-2030
Global Sleep Apnea Devices Market is valued at approximately USD 4.2 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.2% over the forecast period 2023-2030. Sleep apnea device market is devices used to manage breathing in sleep apnea patients. These devices help in steady flow of oxygen and normal breathing. The Sleep Apnea Devices market is expanding because of factors such as the growth in aged population and increase of population being aware of sleep apnea disease. However, the availability of alternative medication for sleep apnea disease and high cost associated with sleep apnea devices tends to lower the market growth.
Increasing Sleep apnea disease and snoring among senior people tends to rise the Sleep Apnea Devices Market. As, according to Sleep Foundation 2022 snoring was affected to 44% of men and 28% of women. This statistic shows snoring percentage among population which results in rise of people trying to cure this problem and buying sleep apnea devices. Additionally, growth in the geriatric population as sleep apnea disease mostly occurs to senior people leads to growth in Sleep apnea devices market. As, according to world health population between 2015 and 2050, the proportion of the world's population over 60 years nearly double from 12% to 22%. Snoring is an early stage of sleep apnea disease. As, according to yale medicine 90 million of Americans snore at one time or another, while 37 million say they snore regularly. Rising in people snoring leads to rise in sleep apnea disease. Increasing focus on treating disease with telemedicine and growing diagnosis rates for sleep apnea further act as an opportunity for the growth of this market. As, according to Journal of sleep medicine effective use of telemedicine for the diagnosis and management of obstructive sleep apnea, to improve adherence to positive airway pressure therapy.
The key regions considered for the Global Sleep Apnea Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 as changing lifestyle and awareness of sleep apnea disease among population, increasing of aged and obese population. Moreover, presence of more key players in this region and increase in disposable income in this region results in growth of this market. Asia Pacific is expected to grow significantly over the forecast period, owing to factors such as the rising commonness of diseases such as cardiovascular diseases, chronic respiratory diseases and more resulting in growth of sleep apnea diseases in this region
Major market player included in this report are:
Fisher & Paykel Healthcare Limited
Itamar Medical Ltd.
Invacare Corporation
Resmed
Natus Medical Incorporated
Phillips Respironics
Curative Medical, Inc.
Som Imaging Informatics Pvt. Ltd
BMC Medical Co., Ltd.
Natus Medical Incorporated
Recent Developments in the Market:
In July 2023, ResMed Acquired Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software this acquisition improves ResMed’s sleep management software solution. The Somnoware platform continues to be an open platform so that sleep labs, pulmonary function testing facilities, and doctors access the results of various testing methods and assist patients who have been diagnosed in receiving the therapy they require more quickly.
In Nov 2020, BMC launched the M1 Mini this product more portable because it fits in the palm of an adult hand. The outer section of the sphere is made transparent and highlighted by double colour injection moulding, perfectly complementing the symmetrical aesthetics. It offered customers three different sorts of modes for different levels of sensitivity: standard, gentle, and female.
In Nov 2021, Philips acquired Cardiologs, Philips add Cardiologs to its portfolio of cardiac diagnostic and monitoring products. The acquisition of Cardiologs by Royal Philips, a world leader in health technology, was made public today. Cardiologs is a medical technology business based in France that uses artificial intelligence (AI) and cloud computing to transform cardiac diagnostics.
Global Sleep Apnea Devices Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Product Type, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Diagnostic Devices
Therapeutic Devices
Sleep Apnea Masks
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Companies Mentioned
Fisher & Paykel Healthcare Limited
Itamar Medical Ltd.
Invacare Corporation
Resmed
Natus Medical Incorporated
Phillips Respironics
Curative Medical, Inc.
Som Imaging Informatics Pvt. Ltd
BMC Medical Co., Ltd.
Natus Medical Incorporated
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.